Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial - Zhu, A; Macarulla, T; Javle, M (JAMA Oncol, 2021)
et al.